Search

Repligen Corp

Cerrado

SectorSanidad

178.35 1.04

Resumen

Variación precio

24h

Actual

Mínimo

174.22

Máximo

177

Métricas clave

By Trading Economics

Ingresos

-3.3M

5M

Ventas

9.9M

204M

P/B

Media del Sector

236.315

48.735

BPA

0.54

Margen de beneficios

2.453

Empleados

2,000

EBITDA

14M

46M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+15.44% upside

Dividendos

By Acuity

Próximas Ganancias

27 oct 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

3.6B

11B

Apertura anterior

177.31

Cierre anterior

178.35

Repligen Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

19 oct 2026, 19:36 UTC

News

Canaccord Genuity raises Repligen Corp's price target to $180.00 from $145.00 while maintaining a Hold rating, reflecting a positive reassessment of the company's value.

16 oct 2026, 22:01 UTC

Repligen Corp is trading lower in after-market hours, following a notable decline since Friday's close amid unusual volatility and positioning near its one-month range low.

15 oct 2026, 20:07 UTC

Repligen Corp shares advanced, reaching a peak before the session's conclusion.

14 oct 2026, 20:07 UTC

Repligen Corp shares are advancing, benefiting from broader market gains, despite pulling back from earlier session highs. The stock is higher since Tuesday's close.

13 oct 2026, 20:07 UTC

News

Repligen Corp shares are advancing as the company prepares to report its third-quarter 2026 financial results on October 27, 2026.

12 oct 2026, 21:03 UTC

Repligen Corp shares advanced during after-market hours on Monday, moving from a low return to a high return.

9 oct 2026, 20:01 UTC

Repligen Corp shares are sharply higher, continuing an upward trajectory since Thursday's close, supported by positive movement in the broader life sciences sector.

8 oct 2026, 20:07 UTC

Repligen Corp shares fell sharply, continuing a downward trend with three consecutive sessions down, despite a brief recovery earlier in the session.

7 oct 2026, 20:01 UTC

News

Repligen Corp. finalized its $1.5 billion acquisition of BioLife Solutions, but shares fell sharply amid ongoing declines following a prior session drop.

6 oct 2026, 21:01 UTC

Repligen Corp's shares traded modestly higher in after-market hours, marking a peak since Tuesday's close despite remaining below the 20-day moving average.

5 oct 2026, 22:15 UTC

News

Repligen Corp plans to acquire BioLife Solutions, contributing to a modest after-market hours gain as the stock remains above its 20-day moving average.

2 oct 2026, 20:07 UTC

Repligen Corp's shares are advancing, reflecting a broader market trend, maintaining strong performance above the 20-day moving average amid notable intraday volatility.

1 oct 2026, 20:02 UTC

Repligen Corp shares fell sharply, breaking a trend of higher daily closes and diverging from recent upward momentum.

30 sept 2026, 21:01 UTC

Repligen Corp is advancing in after-market trading, reflecting broader market gains amid revised Q2 GDP growth and stronger consumer spending.

29 sept 2026, 23:25 UTC

Repligen Corp has seen a modest decline in after-market trading, retracing from earlier gains and reflecting unusual volatility compared to Tuesday's close.

28 sept 2026, 20:07 UTC

Repligen Corp shares are higher today, maintaining an upward trajectory since Friday's close, supported by strong performance in the life sciences sector.

25 sept 2026, 21:01 UTC

Repligen Corp's shares advanced modestly higher during after-market hours, reflecting strong performance and favorable conditions above their 20-day moving average.

24 sept 2026, 22:05 UTC

Repligen Corp's shares advanced modestly higher in after-market trading, currently 9.33% above its 20-day moving average and near the upper end of its one-month range.

23 sept 2026, 23:46 UTC

Repligen Corp's stock declined in after-market trading, hitting its lowest point of the day after Wednesday's close, despite remaining above its 20-day moving average.

22 sept 2026, 20:13 UTC

Repligen Corp's shares advanced modestly in after-market trading, maintaining strength and staying significantly above its 20-day moving average.

21 sept 2026, 20:06 UTC

Correlated Moves

Repligen Corp is advancing, supported by sympathy with Agilent Technologies' new product launch, and is performing strongly above its 20-day moving average.

18 sept 2026, 19:16 UTC

Repligen Corp shares fell modestly, fluctuating between small gains and losses, despite remaining above the 20-day moving average and near the one-month range.

16 sept 2026, 19:16 UTC

Repligen Corp shares fell after briefly rising, retracing from earlier gains in Wednesday's trading session following three consecutive sessions of increases.

15 sept 2026, 20:07 UTC

Correlated Moves

Repligen Corp is higher today, moving alongside Revvity Inc amid a broader market decline following a drop in the NY Empire State Manufacturing Index.

14 sept 2026, 19:46 UTC

Repligen Corp shares are higher today, continuing an upward trend since Friday. The stock has fluctuated within a range during the session.

11 sept 2026, 21:01 UTC

Repligen Corp shares are higher in after-market trading, continuing an upward trend since Friday's close. The stock remains below its 20-day moving average.

10 sept 2026, 20:07 UTC

Repligen Corp shares are lower amid broader market declines following the European Central Bank's interest rate hike and rising Treasury yields.

9 sept 2026, 20:07 UTC

Repligen Corp shares are lower during Wednesday's session, with no specific news identified. The stock remains significantly below its 20-day moving average.

8 sept 2026, 22:21 UTC

Repligen Corp shares declined in after-market trading, falling further from Tuesday's close and remaining near the lower end of their one-month trading range.

2 sept 2026, 19:26 UTC

Repligen Corp shares are higher during Wednesday's session, reaching a session high earlier today. The stock shows resilience amid broader market geopolitical tensions.

Comparación entre iguales

Cambio de precio

Repligen Corp previsión

Precio Objetivo

By TipRanks

15.44% repunte

Estimación a 12 Meses

Media 202.5 USD  15.44%

Máximo 225 USD

Mínimo 180 USD

De acuerdo con 9 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Repligen Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

9 ratings

8

Comprar

1

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Repligen Corp

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
help-icon Live chat